last updated at 16.10.2019

AML SCT - BFM 2007

Allogenic stem cell transplantation for children, adolescents and young adults with relapsed or refractory AML Multi Center Therapy Concept

Status: Aktiv (Rekrutierung geschlossen)

ISRCTN EudraCT Clinicaltrials.gov DRKS
2007-004517-34 NCT00606723

Diagnose

  • Akute Leukämien: Akute myeloische Leukämien (AML)

Studienziel / Fragestellung

Patientenmerkmale

Alter

-21

Ausschlusskriterien

     

  • Severe renal impairment
  • Pregnant or lactating females
  • Current participation in another clinical trial
  •  

Einschlusskriterien

     

  • Aged between 0-21 years
  • Patients suffering from either refractory de novo AML or relapsed AML or patients with very high risk AML in CR1
  • In sexually active patients two reliable contraception methods are used. This includes every combination of a hormonal contraceptive (such as injection, transdermal patch, implant, cervical ring) or of an intrauterine device(IUD) with a barrier method (e.g. diaphragm, cervical cap, or condom) or with a spermicide.
  • Written informed consent of patient, parents or legal guardians
  •  

Studiendesign

  • Multizentrisch
  • Phase II

Intervention

Dokumente (passwortgeschützt)

Zuständigkeiten Gesamtstudie

Sponsor

  • Hannover Clinical Trial Center GmbH

Prüfzentrum 1

 

  • Klinik für Kinder-Onkologie
  • -Hämatolgie und Immunologie

zurück